Creating a tumor bank for blood samples from cancer patients and healthy controls
Establishment of a Blood Sample Bank in the Field of Gynaecological Oncology.
This study is collecting blood samples from cancer patients and healthy people to help researchers find better ways to diagnose and treat cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical University of Vienna Academic / other |
| Locations | 6 sites (Innsbruck and 5 other locations) |
| Trial ID | NCT01763125 on ClinicalTrials.gov |
What this trial studies
This study aims to establish a tumor bank that collects blood samples from patients with various types of cancer, including ovarian, breast, colorectal, and lung neoplasms, as well as healthy individuals for comparison. The collected samples will be accompanied by corresponding clinical data to facilitate future research in cancer diagnosis and treatment. By systematically gathering these biological samples, the study seeks to enhance translational oncology efforts, bridging laboratory findings with clinical applications to improve patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18 to 90 with a single known malignant or inflammatory disease.
Not a fit: Patients with multiple malignancies, inflammatory diseases alongside malignancies, or those under 18 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this tumor bank could significantly advance cancer research and lead to improved diagnostic and therapeutic strategies for patients.
How similar studies have performed: Other studies have successfully established tumor banks, indicating that this approach is both viable and beneficial for advancing cancer research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male/Female * Age 18 to 90 years max. * Just one current known malignant disease or * Just one current inflammatory disease Exclusion Criteria: * Inflammatory disease and malignant disease * multiple malignancies * multiple diseases * underage
Where this trial is running
Innsbruck and 5 other locations
- Innsbruck Medical University — Innsbruck, Austria (Completed)
- University Hospitals Leuven - Department of Obstetrics and Gynaecology — Leuven, Belgium (Completed)
- Charité University - Campus Virchow Chlinic — Berlin, Germany (Recruiting)
- University Medical Center Freiburg — Freiburg im Breisgau, Germany (Completed)
- University Clinic of Ruhr University Bochum — Herne, Germany (Completed)
- European Institute of Oncology, Division of Gynecologic Oncology, Unit of Preventive Gynecology — Milan, Italy (Withdrawn)
Study contacts
- Principal investigator: Robert Zeillinger, Prof.Dr. — Medical University Vienna, Dept. of Obstetrics & Gynaecology
- Study coordinator: Robert Zeillinger, Prof. Dr.
- Email: robert.zeillinger@meduniwien.ac.at
- Phone: +43140400
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.